Insights from 2023 ASH Annual Meeting
Playback speed
10 seconds
ASH 2023 Insights: "Quizartinib, Venetoclax, & Decitabine Triple Combination in FLT3-ITD-Mutated AML"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Musa Yilmaz
By
Insights from 2023 ASH Annual Meeting
FEATURING
Musa Yilmaz
55 views
December 15, 2023
Login to view comments.
Click here to Login
Leukemia